Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GRM1 | Q13255 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | XIAP | P98170 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407902 | 1.00 | MEN1 (0.39) | MEN1KMT2ACYP1A2CYP3A4GRM1 | |
| SCHEMBL11376459 | 0.81 | LMNA (0.48) | KMT2ACYP2C19LMNAALDH1A1MAPK1 | |
| SCHEMBL24044801 | 0.80 | MEN1 (0.48) | MEN1KMT2ACYP1A2CYP3A4GRM1 | |
| SCHEMBL2928008 | 0.78 | PTGS2 (0.43) | CYP3A4CYP2C19LMNAALDH1A1MAPK1 | |
| SCHEMBL2802851 | 0.78 | CYP1A2 (0.37) | CYP1A2CYP2C19LMNAALDH1A1MAPK1 | |
| SCHEMBL27537238 | 0.76 | SLC1A2 (0.37) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL9960123 | 0.76 | ALDH1A1 (0.44) | MEN1KMT2ATDP1LMNAALDH1A1 | |
| SCHEMBL7993792 | 0.74 | CYP2C19 (0.45) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL27954218 | 0.74 | SRC (0.38) | CYP2C19LMNAALDH1A1MAPK1AKT1 | |
| SCHEMBL2944385 | 0.73 | ALDH1A1 (0.46) | MEN1KMT2ACYP3A4TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114126590-B | Pharmaceutical preparation and method for producing the same | 富士制药工业股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-114126590-A | Pharmaceutical preparation and process for producing the same | 富士制药工业股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3960240-B1 | PHARMACEUTICAL PREPARATION AND METHOD FOR PRODUCING SAME | FUJI PHARMA CO LTD (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-114126590-B | Pharmaceutical preparation and method for producing the same | 富士制药工业股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20220211688-A1 | PHARMACEUTICAL PREPARATION AND METHOD FOR PRODUCING THE SAME | FUJI PHARMA CO., LTD. (JP) | 2022-07-07 | — | — | US | disclosed |
| EP-3960240-A1 | PHARMACEUTICAL PREPARATION AND METHOD FOR PRODUCING SAME | Fuji Pharma Co., Ltd. (JP) | 2022-03-02 | — | — | EP | disclosed |
| CN-114126590-A | Pharmaceutical preparation and process for producing the same | 富士制药工业股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-0335560-B2 | Controlled release pharmaceutical preparation and method for producing the same | TANABE SEIYAKU CO (JP) | 2002-01-23 | — | — | EP | disclosed |
| US-5254347-A | Coating core with porous film of hydrophobic polymer | TANABE SEIYAKU CO., LTD. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0335560-B1 | CONTROLLED RELEASE PHARMACEUTICAL PREPARATION AND METHOD FOR PRODUCING THE SAME | Tanabe Seiyaku Co., Ltd. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-5068112-A | Core containing active ingredient and succinic acid with surface porous film of cellulose | TANABE SEIYAKU CO., LTD. (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0335560-A2 | Controlled release pharmaceutical preparation and method for producing the same | Tanabe Seiyaku Co., Ltd. (JP) | 1989-10-04 | — | — | EP | disclosed |
| US-4443497-A | DISSOLVING, COATING, SOLVENTS, POLYMER, ETHYL CELLULOSE, ANTICOAGULANTS, DRUGS | TANABE SEIYAKU CO., LTD. (JP) | 1984-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211688-A1 | PHARMACEUTICAL PREPARATION AND METHOD FOR PRODUCING THE SAME | CDK9, CDK19, CHD9 | MEN1 3115/4885KMT2A 900/4885CYP1A2 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.